Mattessich Antony C. Insider Trading Activity

Average Profitability
7.2%
Insider Buys Quantity
6
Insider Buys Sum
$837,679.00
Insider Sells Quantity
3
Insider Sells Sum
$269,629.78

Insider Activity of Mattessich Antony C.

Biography of Mattessich Antony C.

No biography is available at this moment.

2024-02-05SaleOcular Therapeutix, Inc.
OCUL
President and CEO
19,642
0.0177%
$4.86$95,460+70.3%
2024-01-31SaleOcular Therapeutix, Inc.
OCUL
President and CEO
18,338
0.0168%
$4.95$90,773+73.46%
2023-08-30PurchaseOcular Therapeutix, Inc.
OCUL
President and CEO
6,500
0.0082%
$3.81$24,765+37.01%
2023-02-06SaleOcular Therapeutix, Inc.
OCUL
President and CEO
19,669
0.0255%
$4.24$83,397+6.12%
2021-08-20PurchaseOcular Therapeutix, Inc.
OCUL
President and CEO
5,000
0.0065%
$9.89$49,450-45.35%
2019-06-06PurchaseOcular Therapeutix, Inc.
OCUL
President & CEO
80,000
0.1878%
$2.81$224,800+60.93%
2018-08-20PurchaseOcular Therapeutix, Inc.
OCUL
President & CEO
40,000
0.1008%
$5.95$238,000-26.78%
2018-08-10PurchaseOcular Therapeutix, Inc.
OCUL
President and CEO
33,800
0.0868%
$6.23$210,574-28.3%
2017-12-12PurchaseOcular Therapeutix, Inc.
OCUL
President and C.E.O.
21,000
0.0732%
$4.29$90,090+45.67%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.